Role of natural killer cells in the pathogenesis and progression of multiple sclerosis

Pharmacological Research

Volumn 57, Issue 1, 2008, Pages 1-5

  Morandi, Barbara ^a   Bramanti, Placido ^b   Bonaccorsi, Irene ^a   Montalto, Erika ^a   Oliveri, Daniela ^a   Pezzino, Gaetana ^a   Navarra, Michele ^a,b   Ferlazzo, Guido ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Autoimmunity; Multiple sclerosis; Natural killer cells

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; HLA E ANTIGEN; INTERLEUKIN 21; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AUTOIMMUNITY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DISEASE COURSE; DISEASE PREDISPOSITION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS;

EID: 39149089995     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.11.003     Document Type: Review

References (57)

1. McFarlin D.E., and McFarland H.F. Multiple sclerosis (first of two parts). N Engl J Med 307 (1982) 1183-1188
2. McFarlin D.E., and McFarland H.F. Multiple sclerosis (second of two parts). N Engl J Med 307 (1982) 1246-1251
3. Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol 2 (2001) 762-764
4. Wanstrat A., and Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2 (2001) 802-809
5. Garza K.M., Chan S.M., Suri R., Nguyen L.T., Odermatt B., Schoenberger S.P., et al. Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med 191 (2000) 2021-2027
6. Regner M., and Lambert P.H. Autoimmunity through infection or immunization?. Nat Immunol 2 (2001) 185-188
7. Shi F., Ljunggren H.G., and Sarvetnick N. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol 22 (2001) 97-101
8. Fearon D.T., and Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science 272 (1996) 50-53
9. Bendelac A., and Fearon D.T. Innate pathways that control acquired immunity. Curr Opin Immunol 9 (1997) 1-3
10. Medzhitov R., and Janeway Jr. C.A. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9 (1997) 4-9
11. Carrol M.C., and Prodeus A.P. Linkages of innate and adaptive immunity. Curr Opin Immunol 10 (1998) 36-40
12. Trinchieri G. Biology of natural killer cells. Adv Immunol 47 (1989) 187-193
13. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19 (2001) 197-223
14. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., et al. Receptors for HLA-class I-molecules in human natural killer cells. Annu Rev Immunol 14 (1996) 619-648
15. Lanier L.L. NK cell receptors. Annu Rev Immunol 16 (1998) 359-393
16. Long E.O. Regulation of immune response through inhibitory receptors. Annu Rev Immunol 17 (1999) 875-904
17. Lopez-Botet M., Perez-Villar J.J., Carretero M., Rodriguez A., Melero I., Bellon T., et al. Structure and function of the CD94 C-type lectin receptor complex involved in the recognition of HLA class I molecules. Immunol Rev 155 (1997) 165-174
18. Gilmour K.C., Fujii H., Cranston T., Davies E.G., Kinnon C., and Gaspar H.B. Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency. Blood 98 (2001) 877-879
19. Biron C.A., Byron K.S., and Sullivan J.L. Severe herpes virus infections in an adolescent without natural killer cells. N Engl Med 320 (1989) 1731-1735
20. Zimmer J., Bausinger H., and de la Salle H. Autoimmunity mediated by innate immune effector cells. Trends Immunol 22 (2001) 300-301
21. Moins-Teisserenc H.T., Gadola S.D., Cella M., Dunbar P.R., Exley A., Blake N., et al. Association of a syndrome resembling Wegeber's granulomatosis with low surface expression of HLA class I molecules. Lancet 354 (1999) 1598-1603
22. Kerschensteiner M., Stadelmann C., Dechant G., Wekerle H., and Hohlfeld R. Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 53 3 (2003) 292-304
23. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., et al. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 20 14 (2000) 5283-5291
24. Backstrom E., Chambers B.J., Ho E.L., Naidenko O.V., Mariotti R., Fremont D.H., et al. Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur J Immunol 33 1 (2003) 92-100
25. Morse R.H., Seguin R., McCrea E.L., and Antel J.P. NK cell-mediated lysis of autologous human oligodendrocytes. J Neuroimmunol 116 1 (2001) 107-115
26. Antel J.P., McCrea E., Ladiwala U., Qin Y.F., and Becher B. Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: relation with CD56 expression. J Immunol 160 4 (1998) 1606-1611
27. Takahashi K., Aranami T., Endoh M., Miyake S., and Yamamura T. The regulatory role of natural killer cells in multiple sclerosis. Brain 127 (2004) 1917-1927
28. Takahashi K., Miyake S., Kondo T., Terao K., Hatakenaka M., Hashimoto S., et al. Natural killer type 2 bias in remission of multiple sclerosis. J Clin Ivest 107 (2001) R23-R29
29. Loza M.J., Zamai L., Azzoni L., Rosati E., and Perussia B. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 99 (2002) 1273-1281
30. bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. PNAS 103 (2006) 5941-5946
31. Ortaldo J.R., and Young H.A. Expression of IFN-γ upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors. J Immunol 170 (2003) 1763-1769
32. Suzuki H., Duncan G., Takimoto H., and Mak T.W. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain. J Exp Med 185 (1997) 499-505
33. Fehniger T.A., and Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood 97 (2001) 14-32
34. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9 (1998) 669-676
35. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191 (2000) 771-780
36. H1 response in IL-18-deficient mice. Immunity 8 (1998) 383-390
37. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 (1998) 143-150
38. Kim S., Iizuka K., Aguila H.L., Weissman I.L., and Yokoyama W.M. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci USA 97 (2000) 2731-2736
39. Townsend M.J., Weinmann A.S., Matsuda J.L., Salomon R., Farnham P.J., Biron C.A., et al. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20 (2004) 477-494
40. Zhang B., Yamamura T., Kondo T., Fujiwara M., and Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186 (1997) 1677-1687
41. Matsumoto Y., Kohyama K., Aikawa Y., Shin T., Kawazoe Y., Suzuki Y., et al. Role of natural killer cells and TCR γδT cells in acute autoimmune encephalomyelitis. Eur J Immunol 28 (1998) 1681-1688
42. Smeltz R.B., Wolf N.A., and Swanborg R.H. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity. J Immunol 163 (1999) 1390-1397
43. Sh F.D., Takeda K., Akira S., Sarvetnick N., and Ljunggren H.G. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-γ by NK cells. J Immunol 165 (2000) 3099-3104
44. Vollmer T.L., Liu R., Price M., Rhodes S., La Cava A., and Shi F.D. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 174 (2005) 2696-2701
45. Strengell M., Matikainen S., Siren J., Lehtonen A., Foster D., Julkunen I., et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol 170 (2003) 5464-5469
46. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8 (1998) 275-283
47. H2 responses: a key role for the 'natural' immune response?. Immunol Today 13 (1992) 379-381
48. Morandi B., Bougras G., Muller W.A., Ferlazzo G., and Munz C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur J Immunol 36 (2006) 2394-2400
49. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5 (2004) 1260-1265
50. Chambers B.J., Salcedo M., and Ljunggren H.G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5 (1996) 311-317
51. Wilson J.L., Heffler L.C., Charo J., Scheynius A., Bejarano M.T., and Ljunggren H.G. Targeting of human dendritic cells by autologous NK cells. J Immunol 163 (1999) 6365-6370
52. Andrews D.M., Scalzo A.A., Yokoyama W.M., Smyth M.J., and Degli-Esposti M.A. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 4 (2003) 175-181
53. Piccioli D., Sbrana S., Melandri E., and Valiante N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195 (2002) 335-341
54. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., and Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195 (2002) 327-333
55. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., and Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195 (2002) 343-351
56. Hanna J., Gonen-Gross T., Fitchett J., Rowe T., Daniels M., Arnon T.I., et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 114 (2004) 1612-1623
57. Lu L., Ikizawa K., Hu D., Werneck M.B., Wucherpfenning K.W., and Cantor H. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26 (2007) 593-604